Literature DB >> 23139209

FoxM1 and Wnt/β-catenin signaling in glioma stem cells.

Aihua Gong1, Suyun Huang.   

Abstract

Cancer stem cells may be responsible for tumor initiation and maintenance. The molecular mechanisms that control cancer stem cells are related to alterations in various signaling pathways, including the Wnt/β-catenin signaling pathway. The canonical Wnt/β-catenin signaling pathway is one of the major signaling systems in stem and progenitor cells, and aberrant activation of the Wnt/β-catenin signaling pathway is common in human cancers. As with β-catenin, FoxM1 has been found to play important roles in a number of cancers. In this review, we discuss the evidence that FoxM1 affects the expression and function of a variety of genes that are critical to the survival, proliferation, invasion, angiogenesis, and self-renewal of cancer stem cells. We highlight the pivotal roles of the Wnt/β-catenin and FoxM1 signaling pathways in neural stem and progenitor cells and glioma stem cells. We also discuss the evidence for cross-talk between the β-catenin and FoxM1 signaling pathways in the regulation of the stemness and tumorigenicity of glioma stem cells. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139209      PMCID: PMC3500394          DOI: 10.1158/0008-5472.CAN-12-0953

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  Wnt/β-catenin signaling and disease.

Authors:  Hans Clevers; Roel Nusse
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Effects of canonical Wnt signaling on dorso-ventral specification of the mouse telencephalon.

Authors:  Mattias Backman; Ondrej Machon; Line Mygland; Christiaan Johannes van den Bout; Weimin Zhong; Makoto M Taketo; Stefan Krauss
Journal:  Dev Biol       Date:  2005-03-01       Impact factor: 3.582

3.  Cell-autonomous beta-catenin signaling regulates cortical precursor proliferation.

Authors:  Gregory J Woodhead; Christopher A Mutch; Eric C Olson; Anjen Chenn
Journal:  J Neurosci       Date:  2006-11-29       Impact factor: 6.167

4.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.

Authors:  Galina A Gusarova; I-Ching Wang; Michael L Major; Vladimir V Kalinichenko; Timothy Ackerson; Vladimir Petrovic; Robert H Costa
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

5.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.

Authors:  D S Rickman; M P Bobek; D E Misek; R Kuick; M Blaivas; D M Kurnit; J Taylor; S M Hanash
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

6.  Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.

Authors:  B Dai; S-H Kang; W Gong; M Liu; K D Aldape; R Sawaya; S Huang
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

7.  The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.

Authors:  Yuichi Yoshida; I-Ching Wang; Helena M Yoder; Nicholas O Davidson; Robert H Costa
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

8.  Stem cell division is regulated by the microRNA pathway.

Authors:  S D Hatfield; H R Shcherbata; K A Fischer; K Nakahara; R W Carthew; H Ruohola-Baker
Journal:  Nature       Date:  2005-06-08       Impact factor: 49.962

9.  FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

Authors:  Mingguang Liu; Bingbing Dai; Shin-Hyuk Kang; Kechen Ban; Feng-Ju Huang; Frederick F Lang; Kenneth D Aldape; Tong-xin Xie; Christopher E Pelloski; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

10.  Wnt signalling regulates adult hippocampal neurogenesis.

Authors:  Dieter-Chichung Lie; Sophia A Colamarino; Hong-Jun Song; Laurent Désiré; Helena Mira; Antonella Consiglio; Edward S Lein; Sebastian Jessberger; Heather Lansford; Alejandro R Dearie; Fred H Gage
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

View more
  82 in total

1.  PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.

Authors:  Lei Shi; Xifeng Fei; Zhimin Wang; Yongping You
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-14       Impact factor: 2.416

2.  Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.

Authors:  Vaibhav Chand; Akshay Pandey; Dragana Kopanja; Grace Guzman; Pradip Raychaudhuri
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

3.  Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.

Authors:  Dragana Kopanja; Akshay Pandey; Megan Kiefer; Zebin Wang; Neha Chandan; Janai R Carr; Roberta Franks; Dae-Yeul Yu; Grace Guzman; Ajay Maker; Pradip Raychaudhuri
Journal:  J Hepatol       Date:  2015-03-28       Impact factor: 25.083

4.  Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation.

Authors:  Yaohui Chen; Yu Li; Jianfei Xue; Aihua Gong; Guanzhen Yu; Aidong Zhou; Kangyu Lin; Sicong Zhang; Nu Zhang; Cara J Gottardi; Suyun Huang
Journal:  EMBO J       Date:  2016-02-24       Impact factor: 11.598

Review 5.  Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.

Authors:  Xiao Liu; Kaiyue Wang; Xing Wei; Tian Xie; Bin Lv; Qian Zhou; Xiaoying Wang
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

6.  Association of FOXM1 expression with tumor histology and prognosis in Wilms tumor: Potential for a new prognostic marker.

Authors:  Nadja Apelt; Jochen Hubertus; Doris Mayr; Norbert Graf; Rhoikos Furtwängler; Dietrich Von Schweinitz; Roland Kappler
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

7.  mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells.

Authors:  Daming Zhang; Guang Yang; Xin Chen; Chunmei Li; Lu Wang; Yaohua Liu; Dayong Han; Huailei Liu; Xu Hou; Weiguang Zhang; Chenguang Li; Zhanqiang Han; Xin Gao; Shiguang Zhao
Journal:  J Mol Neurosci       Date:  2014-01-28       Impact factor: 3.444

8.  Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.

Authors:  Bin Dai; Yisong Zhang; Peng Zhang; Changcun Pan; Cheng Xu; Weiqing Wan; Zhen Wu; Junting Zhang; Liwei Zhang
Journal:  Tumour Biol       Date:  2016-01-06

9.  Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.

Authors:  Ulf D Kahlert; Abigail K Suwala; Katharina Koch; Manabu Natsumeda; Brent A Orr; Masanori Hayashi; Jarek Maciaczyk; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

Review 10.  Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells.

Authors:  Soumya M Turaga; Justin D Lathia
Journal:  CNS Oncol       Date:  2016-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.